Open Access

Ligustrazine ameliorates lipopolysaccharide‑induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway

  • Authors:
    • Guangming Li
    • Sisi Liu
    • Huili Wang
    • Rui Pan
    • Haijie Tang
    • Xueqin Yan
    • Yanping Wang
    • Yongmei Fu
    • Fujun Jing
    • Jun Dong
  • View Affiliations

  • Published online on: March 20, 2020     https://doi.org/10.3892/ijmm.2020.4548
  • Pages: 1711-1720
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Autophagy is a lysosome‑mediated cell content‑dependent degradation pathway that leads to enhanced inflammation in an uncontrolled state. This study examined the role of autophagy in lipopolysaccharide (LPS)‑induced brain inflammation and the effects of the traditional Chinese medicine ligustrazine on LPS‑induced neurocognitive impairment in rats. Furthermore, the molecular mechanisms by which ligustrazine influences neurocognitive impairments were explored. The production of the inflammatory mediators interleukin (IL)‑1β and tumor necrosis factor (TNF)‑α was analyzed using ELISAs, and the expression levels of the autophagy marker microtubule‑associated protein light chain 3 (LC3) II/I were analyzed using western blotting. LPS exposure upregulated the expression of IL‑1β and TNF‑α and downregulated the expression of LC3 II/I. Ligustrazine activated autophagy by preventing the expression of phosphoinositide 3‑kinase (PI3K), phosphorylated protein kinase B (p‑AKT), and phosphorylated mammalian target of rapamycin (p‑mTOR). The present results suggest that ligustrazine improved LPS‑induced neurocognitive impairments by activating autophagy and ameliorated neuronal injury by regulating the PI3K/AKT/mTOR signaling pathway. These findings provide an important reference for the prevention and treatment of neuroinflammation.
View Figures
View References

Related Articles

Journal Cover

June-2020
Volume 45 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li G, Liu S, Wang H, Pan R, Tang H, Yan X, Wang Y, Fu Y, Jing F, Dong J, Dong J, et al: Ligustrazine ameliorates lipopolysaccharide‑induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway. Int J Mol Med 45: 1711-1720, 2020
APA
Li, G., Liu, S., Wang, H., Pan, R., Tang, H., Yan, X. ... Dong, J. (2020). Ligustrazine ameliorates lipopolysaccharide‑induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway. International Journal of Molecular Medicine, 45, 1711-1720. https://doi.org/10.3892/ijmm.2020.4548
MLA
Li, G., Liu, S., Wang, H., Pan, R., Tang, H., Yan, X., Wang, Y., Fu, Y., Jing, F., Dong, J."Ligustrazine ameliorates lipopolysaccharide‑induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway". International Journal of Molecular Medicine 45.6 (2020): 1711-1720.
Chicago
Li, G., Liu, S., Wang, H., Pan, R., Tang, H., Yan, X., Wang, Y., Fu, Y., Jing, F., Dong, J."Ligustrazine ameliorates lipopolysaccharide‑induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway". International Journal of Molecular Medicine 45, no. 6 (2020): 1711-1720. https://doi.org/10.3892/ijmm.2020.4548